GlaxoSmithKline Biologicals; Branch of SmithKline Beecham Pharma GmbH & Co. KG
发明人:
Eichhorn, Uwe
申请号：
AU2006200742
公开号：
AU2006200742C9
申请日:
2006.02.22
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2006200742C920150326.pdf#####ABSTRACT An inactivated influenza virus preparation is described which comprises a haemagglutinin antigen stabilised in the absence of thiomersal, or at low levels of thiomersal, wherein the 5 haemagglutinin is detectable by a SRD assay. The influenza virus preparation may comprise a micelle modifying excipient, for example a-tocopherol or a derivative thereof in a sufficient amount to stabilise the haemagglutinin. Anti AINewCatedonia (H1NI) 300 1W 0 9Pg4MWj SGra 0 61 62 64 Anti 800Uannesburg M. 15 ftteuwe 10 G1 ? 63 64 Gre Iesf~bu
